ArticlePDF Available

Abstract and Figures

Digital health interventions (DHIs) have the potential to help the growing number of chronic disease patients better manage their everyday lives. However, guidelines for the systematic development of DHIs are still scarce. The current work has, therefore, the objective to propose a framework for the design and evaluation of DHIs (DEDHI). The DEDHI framework is meant to support both researchers and practitioners alike from early conceptual DHI models to large-scale implementations of DHIs in the healthcare market.
Content may be subject to copyright.
     
          
     
 

         
  
 Digital health interventions (DHIs) have the po-
tential to help the growing number of chronic disease pa-
tients better manage their everyday lives. However, guide-
lines for the systematic development of DHIs are still
scarce. The current work has, therefore, the objective to
propose a framework for the design and evaluation of DHIs
(DEDHI). The DEDHI framework is meant to support both
researchers and practitioners alike from early conceptual
DHI models to large-scale implementations of DHIs in the
healthcare market.
 barriers, criteria, digital health intervention,
evaluation, life cycle, recommendations
  CCS Applied computing Life and medical
sciences Health care information systems

Over the last decades, the prevalence of chronic health
problems, i. e. diseases, conditions, and syndromes that
are continuing or occurring repeatedly for a long time, is
steadily increasing. Chronic health problems include, for
example, cardiovascular diseases, diabetes, chronic respi-
ratory diseases (e. g., COPD or asthma), arthritis or certain
types of cancer (e. g., multiple myeloma) [10, 46, 53]. These
health problems lead not only to a substantial decrease in
       
       
       
      
      
 

       
     
   

       
      
       
  

the quality of life of those being aected [33, 41, 68] or loss
in productivity [64] but represent also the most important
economic challenge in developed countries with up to 86
percent of all healthcare expenditures [12, 46, 53].
In addition to current approaches to address this im-
portant problem, for example, through national chronic
disease strategies and policies [89], the use of information
technology to either monitor health conditions and behav-
ior or to deliver health interventions is another promis-
ing approach to support the growing number of chronic
patients in their everyday lives [1, 53]. In this article, we
use the term digital health intervention (DHI), describing
the action of intervening [66] with “tools and services that
use information and communication technologies (ICTs)
to improve prevention, diagnosis, treatment, monitoring
and management of health and lifestyle” [26], which is
closely related to the notion of mHealth, telemedicine,
telecare and health IT [28].
In light of the mature history of evidence-based
medicine with clear guidelines on how to develop and as-
sess the eectiveness of biomedical or behavioral health
interventions [70, 82], up till now, guidelines for the sys-
tematic development and assessment of DHIs are still
scarce and corresponding research has just started. For ex-
ample, rst evaluation criteria have been proposed during
the last decade [8, 9, 18, 27, 60, 80, 83]. However, this pre-
liminary work lacks guidance to which degree and when
to apply these criteria along the life cycle of DHIs [63, 78].
Particularly, it is essential to consider appropriate evalua-
tion criteria not only during the conceptual and prototype
phases of a DHI, but also with respect to long-term imple-
mentations in the health care market, so that a sustain-
able, eective and ecient use of DHIs can be achieved.
The evaluation results would also be the foundation for
trust-building certications similar to energy eciency la-
bels of consumer products, which can be used by patients
and health professionals alike to nd the “right” DHIs.
Moreover, barriers for implementation and scaling-up of
DHIs remain [65] that intervention authors must be aware
of and that need to be addressed during and after the de-
velopment process. A successful DHI conclusively needs
to consider both, the selection of suitable evaluation crite-
ria and the overcoming of implementation barriers. There-
fore, a match-making is deemed useful to assess which
evaluation criteria need to be considered and which im-
                   
            
plementation barriers need to be addressed at which par-
ticular phase of a DHI life cycle.
The current work has therefore the objective to pro-
pose a framework for the iterative Design and Evaluation
of DHIs (DEDHI) that describes a typical life cycle of a DHI
and recommends relevant evaluation criteria and imple-
mentation barriers to be considered for each phase of this
life cycle.
The DEDHI framework is meant to support both re-
searchers and practitioners alike during the design and
evaluation of various instantiations of DHIs, i. e., from
conceptual models to large-scale implementations in the
healthcare area. The scientic contribution lies in the
alignment of research streams from dierent elds at the
intersection of behavioral medicine (e. g., behavioral in-
terventions), medical informatics (e. g., medical applica-
tions) and information systems research (e.g., barriers of
health information systems, including aspects of technol-
ogy acceptance).
The remainder of this article is structured as follows.
Design and evaluation frameworks for health interven-
tions and DHI life cycle models are presented in the next
section which build the foundation of the proposed DEDHI
framework. For this purpose, an extended version of the
multiphase-optimization strategy (MOST) [19, 20, 21] is
used as the guiding life cycle model. Then, a systematic
literature review is described and a consolidated list of
evaluation criteria for DHIs are presented. Afterwards and
based on a previous literature review [65], a consolidated
list of implementation barriers for DHIs are outlined. In
the following main results section, the consolidated eval-
uation criteria and implementation barriers for DHIs are
both mapped to the DEDHI framework. This mapping is
conducted in a deductive manner by applying qualitative
content analysis [55]. Finally, the resulting DEDHI frame-
work is discussed with recommendations for research and
practice, and limitations. A summary and suggestions for
future work conclude this article.
  
  
    

Various design and evaluation frameworks for health in-
terventions have been proposed in the past. Examples of
these frameworks are listed in Table 1. They range from
guidelines for the development of public health interven-
         

  

 
 
 
  
  
 
  


  

 
  
   


 
  
 
 
 
  

  
  
   

 
 
  

  
  
  

 




 
   
 
  
 



 
 
 

  
  
 
 

 
 
 
  
 
   
  



  
 
 
 
  
 
   


 
 
  
  
 
  
    
 
 

 
  


 

 
  
 
 


 
tions [87] and policies [24] at the population-level to be-
havioral health interventions [56] and DHIs [59] at the
individual-level. A common shortcoming of these frame-
works, however, lies in the lack of guidance with respect to
evaluation criteria and implementation barriers along the
dierent phases of a typical DHI life cycle. That is, appro-
priate guidance is missing from the conceptual model of a
DHI to a product-grade DHI that is maintained in the long-
term. In particular, none of these frameworks oers guid-
ance on technology-related aspects (e. g. maturity, scala-
bility or security) and there are only a few frameworks that
consider the implementation phase explicitly [16, 22].
To address these shortcomings, ndings from DHI life-
cycle models [13, 39, 47, 77] can be used. These mod-
            
els describe the phases that systems undergo while they
evolve from a prototypical development to an operational
product [84]. For example, Broens etal. [13] proposed a
four-layered life-cycle model. It distinguishes between the
phases of prototypes, small-scale pilots, large-scale pilots,
operational product and links specic determinants of
successful DHI implementations to each of these phases.
The generic Technology Readiness Level model also fol-
lows this structure but renes the initialization and pro-
totype phases in a more granular way [54].
Against this background and in order to account for
all relevant phases of DHI development and implementa-
tion, we propose an extended version of MOST [19, 20, 21]
as the guiding life cycle model for DEDHI. It was selected,
because (a) it describes the development of DHIs in a rig-
orous and iterative way with several design, optimization
and evaluation steps and clearly dened optimization cri-
teria, (b) it explicitly considers a novel class of personal-
ized and promising health interventions, i.e., just-in-time
adaptive interventions [61, 62] and corresponding assess-
ment methods such as micro-randomized trials [48] that
heavily rely on the use of technology and, nally, (c) be-
cause it also focuses on behavioral health interventions
at the individual-level which is relevant for chronic health
problems [46, 53]. Due to the fact that MOST does not con-
sider a phase after a DHI has been successfully evaluated
in a randomized controlled trial, a corresponding imple-
mentation phase is added from both related design and
evaluation frameworks from Table 1 [15, 16, 22] and a DHI
life cycle model [13]. Moreover, details on recommended
maturity levels of DHI technology are also incorporated
into this extended version of MOST from corresponding
DHI life cycle models [13, 54].
The proposed DEDHI framework, which is based upon
this extended version of MOST, is shown in Table 6. This ta-
ble also includes the consolidated evaluation criteria and
implementation barriers for DHIs which are described in
more detail in the following two sections.
   
A systematic literature review was conducted to identify
evaluation criteria for DHIs. A recently published system-
atic review of quality criteria for mobile health applica-
tions [63] in combination with an explorative search in the
PubMed and Google Scholar databases were used to iden-
tify appropriate search terms that revealed a signicant
amount of relevant search results.
The nal set of search terms is listed in Table 2 and
was applied as follows: (ID1 and ID2 and ID3 and ID4 in
     
   
    
      
  
 
     
     

 
        

      
      
     
    
      
   
  
  
 
 
Title) and (ID1 and ID2 in Abstract) (note that ID refers to
the search term ID listed in Table 2).
The goal of the search strategy was to update and com-
plement prior ndings [63] due to the broader focus of
the current work on DHIs which includes not only mobile
health interventions but also web-based interventions and
hybrid interventions in which also guidance by human
health professionals are foreseen [51]. The resulting search
strategy therefore consisted of three approaches. First, a
backward search was conducted with relevant work al-
ready identied by Nouri et al. [63] but with the broader
focus on DHIs. Here, relevant articles were screened back
to the year 2000, which can be determined as the start
of systematic research on DHIs [3, 4]. Second, the work
of Nouri et al. [63] was updated with the broader DHI fo-
cus and relevant work from December 2016 till May 2019.
Third, the search strategy of Nouri et al. [63] was extended
to socio-technical databases and journals, i. e., ACM Digi-
tal Library, IEEE Explore, and A-ranked and B-ranked dig-
ital health journals as listed in [75]. An overview of the
search strategy is outlined in Table 3.
A search result was included if the work was origi-
nal, peer-reviewed, written in English, and described a
tool with evaluation criteria for DHIs. Thus, systematic re-
views of evaluation criteria were excluded but relevant
work from these reviews was screened when published be-
tween January 2000 and May 2019.
The inclusion of relevant work was initially carried
out by two authors of this article on the basis of title and
abstract. In the event of uncertainty as to whether a par-
ticular work fullled the inclusion criteria, the entire text
was read and, if necessary, a third co-author was con-
sulted. The evaluation criteria with a corresponding def-
            
      
  
  
  


  
   
 
  
  


   
    
  
   
   
  
 


  
   

 
   
inition were then extracted from the resulting list of in-
cluded work. All criteria with corresponding denitions (if
available) were then reviewed independently by two co-
authors and summarized into inductive categories accord-
ing to qualitative content analysis [55]. In case of uncer-
tainty, the two co-authors consulted each other and also
included a third co-author to nd a consensus.
The systematic search led initially to 2616 journal arti-
cles and conference papers which were then screened step
by step as outlined in Figure 1.
Overall, 331 evaluation criteria were then extracted
from the resulting 36 records and consolidated into 13 cate-
gories. These categories are listed in Table 4 and accompa-
nied by a description, references for further readings and
the number of corresponding evaluation criteria.
          
      
        
  =        
      
  
           
      
    




        
    
    
      




       
     
       
     
    




      
      
      
     


        
       
     


       
      
       
    




      
      
    
     
  




      
     
   
      




       
      
  




        
       
        
 




      
        
      



       
       
    
   


         
       
     
    


            
An overview of all selected articles, evaluation crite-
ria and mapping of these criteria to the categories includ-
ing examples is provided in [50]. The results of the con-
solidated categories show that ease of use is by far the
most dominant category, with 87 evaluation criteria. By
contrast, evaluation criteria related to ethical and safety
aspects of a DHI are so far quite neglected by the scien-
tic community. Moreover, it can be observed that one fun-
damental aspect of evidence-based medicine and the pri-
mary objective of design and evaluation frameworks as
outlined in Table 1, i.e., to assess the degree to which an
intervention is eective, does not take over a prominent
position with the eighth rank in Table 4. Finally, it can be
noticed that both subjective evaluation criteria (e. g., per-
ceived benet of a DHI) and criteria measured objectively
(e. g., adherence to a DHI) are listed among the resulting
categories.
   
A list of implementation barriers of DHIs was already
identied in prior work by means of a systematic litera-
ture review of reviews [65]. For the purpose of the current
work, the 98 identied implementation barriers were sum-
marized into inductive categories according to qualitative
content analysis [55]. Out of the 98 barriers, 106 assign-
ments to categories could be made. This higher number is
due to the fact, that some barriers are related to more than
one category. An overview of the resulting categories of im-
plementation barriers, their descriptions and numbers are
shown in Table 5.
   
  
   
The mapping of the evaluation criteria and implementa-
tion barriers for DHIs along the life cycle phases of the
proposed DEDHI framework was conducted by means of
a qualitative content analysis [55]. The analysis was done
by at least two scientists independently, whereby inconsis-
tencies were resolved through discussion until consensus
was reached. The resulting overview of the DEDHI frame-
work, including the mapping of evaluation criteria and im-
plementation barriers, is listed in Table 6.
For each phase of the DEDHI framework, the overall
goal and corresponding design and evaluation tasks are
outlined. These goals and tasks are adapted to the concept
       
   =      
         
  


  

    
    
      
      
      
    


 

     
       
    
    


       
      
 


       
     
 




     
     
  




    
   
      



       
    


       
     


      
      
     
  





        
    



 
 
     
      
   


      
    




    
  


      
 


       
    


     
      


     

       
     


            
  
  


   
       
  




       
   
 


       
        



       
    


       
     
    




       
     





  
  




   
   




    
     
     


of DHIs from MOST [19, 20, 21] for the Phases 1, 2 and 3
and from related work on intervention design and life cy-
cle models [15, 16, 22] for Phase 4 as outlined in Section 2.
In addition, a brief description of the technical maturity
of the DHI is provided to help intervention authors better
understand the technical perspective. Moreover, relevant
evaluation criteria and implementation barriers are pro-
vided for each phase of the DEDHI framework that are sug-
gested to be addressed by intervention authors in order to
create evidence-based DHIs that can be successfully im-
plemented in the health care market.
While almost all criteria and barriers are only related
to a single phase, some are related to two or all phases.
For example, the two barrier categories funding and cost
are related to all the phases as they represent start-up
as well as maintenance cost and funding. Also, some in-
dividual characteristics (e.g., lack of trust in colleagues
[43, 71], lack of trust in politics [71], sticking to old fash-
ioned modalities of care [43]) and negative associations
of healthcare providers relate to more than one phase.
First, they need to be considered within user-centered de-
sign processes in the preparation phase. Second, they can
be addressed during the implementation phase by means
of advertisement and awareness campaigns. Furthermore,
usability also relates to more than one phase. However,
      
        
       
       review existing justicatory
knowledge        
        develop a
conceptual model       
    conduct a feasibility and
acceptability study         
identify an optimization criterion     
      
      
       
       
  
    
        
    
      
   
        
         
      conduct optimization trials
       identify the best DHI
conguration that meets the optimization criterion  
        
         
       
           
    
       
         
    
      
      
      
 
     
       
        
         
  to conduct a randomized controlled trial   
          
        
          
           
  
       
         
   
     
      

      
 
            
  
       
         
   develop a DHI product     
       monitor reach, impact
and side eects        
      
     update the DHI   
           
         
         
        
          
       
       
         
     
     
        

      
       
    
     
     
    
  
dierent facets of the usability category relate to dierent
DEDHI framework phases.
Finally, it must be noted, that some of the implemen-
tation barriers could not be aligned to the DEDHI frame-
work as they cannot be overcome during the life cycle of
DHIs but are instead related to framing conditions. This
includes missing benets, cooperation and responsibili-
ties as well as characteristics of the disease involved which
hinder the usage of DHIs in general.

The DEDHI framework provides an overview of evaluation
criteria and implementation barriers to be considered dur-
ing the life cycle phases of DHIs. All criteria and almost
all barriers could be matched to the four phases. However,
all phases could be linked to dierent numbers of crite-
ria and barriers, which underlines the importance of ad-
dressing both factors during the whole life cycle. Further-
more, it underlines the t of the DEDHI framework regard-
ing the purpose of informing DHI developers and evalua-
tors step-wise about criteria and barriers to be considered.
However, dependencies between criteria (e. g., lower rel-
evance of costs whenever a DHI is easy to use and su-
ciently helpful) were not considered in our work as they
could not be identied by the literature review and con-
tent analysis itself.
The evaluation criteria and implementation barriers
presented in this work originate from dierent countries
and geographic regions, for example, the United States
[30], Europe [36, 69], Australia [69] or Africa [34, 85]. This
shows the universality of the criteria and barriers and with
it, also the universality of the DEDHI framework.
Moreover, it becomes obvious from the current work
that the interdisciplinary eld of Digital Health needs to
integrate and consolidate perspectives and research nd-
ings from various elds such as behavioral medicine (e. g.,
the “active” ingredients of DHIs such as well-established
behavior change techniques), computer science (e. g., ma-
chine learning algorithms embedded in DHIs that detect
critical health conditions), software engineering (e.g., the
rigorous design, implementation and test of DHIs) or in-
formation systems research (e.g., understanding the use
and success factors of DHIs). That is, to better understand
the development and evaluation of DHIs, it is crucial to
broaden the scope and to account for related work at the
intersection of the relevant disciplines involved.
Last but not least, no work comes without limitations
which also applies to this one. First and foremost, the
proposed DEDHI framework was developed purely in an
inductive way based on content analysis techniques and
existing justicatory knowledge. It was therefore not ap-
plied, validated and revised during the development and
evaluation of DHIs in the eld. Thus, empirical evidence
that supports the utility of the DEDHI framework is not es-
tablished yet.
Second, the current work considers ndings from sci-
entic outlets only and thus, incorporates country-specic
regulatory frameworks only indirectly to the extent to
which these regulations are covered by these outlets. That
is, legal frameworks and prescriptions with respect to the
life cycle phases will probably dier in detail and depend
on the class of the (medical) DHIs in comparison to the
more idealistic four phases of DEDHI. With the goal to ac-
celerate the digital transformation of health care, for ex-
ample, the German Ministry of Health proposes the imple-
mentation of easy to use and secure DHIs in a rst phase
before their eectiveness is assessed in a second step [86].
This approach has the advantage, in particular for start-
up companies, that signicant nancial investments of up
to several years (e. g., for optimization and evaluation tri-
als) are not required up-front. Instead, in interdisciplinary
collaborations with digital health (research or business)
organizations, relevant stakeholders such as patient orga-
nizations, health insurance or pharmaceutical companies
            
may take over a signicant amount of these investments
due to the early product character of DHIs. Another advan-
tage is the primary focus on real-world trials compared to
often articial ecacy studies under controlled environ-
ments, for example, with highly selected participants or
study nurses that are experienced with clinical trials [32].
The major shortcoming of such an approach, however, is
the fact that the burden of patients will be increased by
oering DHIs that are (potentially) not eective at all.
Third, the proposed DEDHI framework does not make
an explicit distinction between the goals and motivations
of the various stakeholders interested in the design and
evaluation of DHIs, such as research teams funded by na-
tional research foundations or commercial digital health
companies which are dependent on payers such as health
insurance organizations. While research teams may be pri-
marily interested in the publication of novel digital coach-
ing concepts and their impact on therapy adherence (here,
the focus lies primarily on the preparation phase and op-
timization phase), the primary interest of commercial dig-
ital health companies may be to bring a new DHI as fast
as possible into the healthcare market (here, the focus lies
on the implementation phase). Implications for the doc-
umentation and testing of the DHIs may be very dier-
ent in these cases. For example, the digital health com-
pany must establish well-documented software develop-
ment processes at the very beginning of a new DHI project
as they are hard regulatory requirements when the DHI is
oered in the healthcare market. On the contrary, the very
same regulatory requirements are not relevant for the re-
search team.
And nally, the chosen methods include subjective
procedures. Conducting literature searches and qualita-
tive content analysis is limited by the terms and databases
chosen, and by the subjectivity of the researchers involved.
However, such bias was reduced as much as possible.
For example, relevant databases were included for the
searches and synonyms of search terms were tested for
results. Furthermore, each methodological step was done
by at least two authors independently and inconsistencies
were resolved by discussion and consensus.
   
Due to the lack of well-established design and assessment
guidelines for digital health interventions (DHIs), the cur-
rent work had the objective to propose a framework for
the Design and Evaluation of DHIs (DEDHI). For this pur-
pose, justicatory knowledge from the elds of behavioral
medicine, medical informatics and information systems
was reviewed. Overall, four life cycle phases of DHIs, 331
evaluation criteria and 98 implementation barriers were
identied and consolidated. The resulting DEDHI frame-
work is meant to support both researchers and practition-
ers alike during the various design and evaluation phases
of DHIs.
Future work is advised to critically apply, reect,
validate, and revise the proposed framework with its
components as the eld of Digital Health is still in its
nascent stage. Accordingly, it is recommended that ex-
perts from the elds of ethics, regulatory aairs, public
health, medicine, computer science and information sys-
tems work closely together to pave the way for evidence-
based DHIs. The latter would not only push the eld of
Digital Health forward but it will, rst and foremost, help
a signicant number of individuals to better manage their
chronic health problems in their everyday lifes.
 This work was co-funded by Health Promotion
Switzerland, and the European Social Fund and the Free
State of Saxony (Grant no. 100310385).

         
      Information Systems
Research  
         
        
       JMIR Mhealth
Uhealth  
        
Internet Interventions  
         
      Internet
Interventions  
         
      Addiction
 
     Planning health promotion programs;
an Intervention Mapping approach     
 
        
      
   Health Education & Behavior
 
          
     JAMA 

        
      
   Journal of Medical Internet
Research  
            
          
   Frontiers in Public Health 
  
         
      
     
      
       BMC Health
Services Research  
           
     Europen Journal of
Epidemiology  
        
   Journal of Telemedicine
and Telecare  
           
      
  Journal of Biomedical Informatics
 
        
      BMJ
 
        
     BMJ  
         
   Telemedicine Journal and E-Health
 
       
      
     
   Healthcare
 
   Optimization of Behavioral, Biobehavioral,
and Biomedical Interventions: The Multiphase Optimization
Strategy (MOST)    
         
     Annals of
Behavioral Medicine  
         
      
      
    American Journal of
Preventive Medicine  
        
      
BMJ  
     Health information from the web assessing
its quality: a KET intervention   
       
           
     Bulletin of the World
Health Organization  
     Application of the behaviour change wheel
framework to the development of interventions within the
City4Age project     
    
    
       
 
     
      
  Journal of Medical Internet Research
 
    
 
        
      
 Journal of Pediatric Psychology 

        
     Population
Health Management  
        
      
     
       New England Journal of
Medicine  
          
        PloS One
 
           
     
    Journal of Telemedicine &
Telecare  
      Health program planning: an
educational and ecological approach     
  
         
  Journal of Psychopathology & Behavioral
Assessment  
         
      
  BMC Health Services Research 

         
      
       
Frontiers in Public Health   
        
     
    Bmc Medical Informatics
and Decision Making  
        
      BMC Medicine
 
          
        Health and
Quality of Life Outcomes  
        
      
JMIR Mhealth Uhealth  
          
       
Telemedicine & e-Health  
           
   Healthcare
Informatics Research  
           
     Telemedicine
Journal and E-health  
            
           
  American Journal of Health Promotion
 
         
    Telemedicine and
e-Health  
        
     
Health Psychology  
        A privacy framework for
mobile health and home-care systems   
         
     
 
          
   
 
     Text-based Healthcare Chatbots Supporting
Patient and Health Professional Teams: Preliminary Results of
a Randomized Controlled Trial on Childhood Obesity 
       
       
          
        
 Journal of medical systems  
          
Nature Biotechnology  
        
      Forum: Qualitative
Social Research  
          
       
   Implementation Science
 
           
    JMIR
Public Health & Surveillance  
     Website quality assessment criteria 
     
    
        
        
      
   Journal of medical Internet Research
 
         
   American Journal of Preventive
Medicine  
        
       
    
Health Psychology  
       
       
      Annals of
Behavioral Medicine  
           
   Journal of the American Medical
Informatics Association  
  Health at a Glance: Europe 2016 State of Health in
the EU Cycle    
      Investigating Barriers for the
Implementation of Telemedicine Initiatives: A Systematic
Review of Reviews     
    
      
 
          
       
 JMIR Mhealth Uhealth  
          
        
   Clinical Interventions in Aging
 
         
      Pain Med
 
           
   BMJ  
        
       
International Journal of Medical Informatics 

        
      Journal
of Biomedical Informatics  
      A framework to measure user
experience of interactive online products  
     
      

         
       
    Australasian Journal of Information
Systems  
          
    
Communications of AIS   
        
   Australian Journal
of Rural Health  
        
     Nature Biotechnology
 
           
       JMIR
mhealth and uhealth  
          
        JMIR
Mhealth Uhealth  
          
       JMIR Mhealth
Uhealth  
          
     Interactive Journal of
Medical Research  
        The Lancet
 
         
      World Psychiatry
            
 
        
 International Journal of Environmental Research
and Public Health  
       Comparative usability
evaluation of a mobile health app   
     
        
     
 
          
 Journal of Epidemiology & Community Health
 
         
    Studies in Health Technologie
and Informatics  
         
    Health expectations: an
international journal of public participation in health care and
health policy  

 
    
   
     
   
   
   
   


        
      
          
          
            
          
 
   
  
   


        
           
        
         
      
 
    
   
    
    


       
         
         
        
         
 
 
    
   
    
    


       
         
         
        
         
 
 
   
  
   


           
        
         
      
          
         
    
... Ein weiterer Ansatz für die Auswahl der Outcomes ergibt sich aus dem Prinzip der reifegradabhängigen Evaluation [7,8]. Hierbei wird der Produktlebenszyklus der DI in mehrere Phasen eingeteilt und relevanten Outcomes zugeordnet. ...
... Hierbei wird der Produktlebenszyklus der DI in mehrere Phasen eingeteilt und relevanten Outcomes zugeordnet. Das Design and Evaluation of Digital Health Intervention-Framework gliedert den Entwicklungsprozess (Produktlebenszyklus) einer DI in vier Phasen [7]. In frühen Phasen stehen Outcomes wie die Patient*innensicherheit, die Usability sowie die Servicequalität im Fokus. ...
... Des Weiteren stehen für die Messung der Servicequalität von Telemedizinanwendungen in späteren Phasen der Evaluation bereits eine Vielzahl validierter Messinstrumente in Form von PREM zur Verfügung [9]. In späteren Phasen sollen u. a. die Bewertung der Effektivität, der erwartbare Nutzen sowie der Adhärenz in die Entwicklung mit einfließen [7]. ...
Article
Zusammenfassung Methodische Herausforderungen bei der Evaluation digitaler Interventionen (DI) sind für die Versorgungsforschung allgegenwärtig. Die Arbeitsgruppe Digital Health des Deutschen Netzwerks Versorgungsforschung (DNVF) hat in einem zweiteiligen Diskussionspapier diese Herausforderungen dargestellt und diskutiert. Im ersten Teil wurden begriffliche Abgrenzungen sowie die Entwicklung und Evaluation von DI thematisiert. In diesem zweiten Teil wird auf Outcomes, das Reporting von Ergebnissen, die Synthese der Evidenz sowie die Implementierung von DI eingegangen. Lösungsansätze und zukünftige Forschungsbedarfe zur Adressierung dieser Herausforderungen werden diskutiert.
... Lastly, most existing assessment frameworks focus only on eHealth tools that are fully operational within the market, and do not necessarily tackle those that are still under development or not implemented yet [100]. One of the few assessment frameworks that look into specific criteria for the different phases of development and implementation cycle is the framework for the design and evaluation of digital health interventions (DEDHIs), developed by Kowatsch et al [109] categorizing the assessment criteria according to the phase in which the tool is in: preparation, optimization, evaluation, and implementation. ...
Article
Full-text available
Background: Technological advancements have opened the path to many technology providers to easily develop and introduce eHealth tools to the public. The use of these tools is increasingly recognized as a critical quality driver in healthcare, however, choosing a quality tool in the myriad of tools available for a specific health need doesn't come without challenges. Objective: The aim of this review was to systematically investigate the literature to understand the different approaches and criteria used to assess the quality and impact of eHealth tools by considering sociotechnical factors (from technical, social, and organizational perspectives). Methods: A structured search was completed following the participants, intervention, comparators, and outcomes framework. We searched the PubMed, Cochrane, Web of Science, Scopus, and ProQuest databases for studies published between January 2012 and January 2022 in the English language, yielding 675 results, of which 40 studies met the inclusion criteria. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and the Cochrane Handbook were followed to ensure a systematic process. Extracted data were analyzed using NVivo (QSR International), with a thematic analysis, and narrative synthesis of emergent themes. Results: Similar measures from the different papers, frameworks, and initiatives were aggregated in 36 unique criteria grouped in 13 clusters. Using the sociotechnical approach, we classified the relevant criteria into technical, social, and organizational criteria. The technical assessment criteria were grouped in 5 clusters: technical aspects, functionality, content, data management, and design. The social assessment criteria were grouped in 4 clusters: human centricity, health outcomes, visible popularity metrics, and social aspects. And the organizational assessment criteria were grouped in 4 clusters: sustainability and scalability, health care organization, health care context, and developer. Conclusions: This review builds on the growing body of research that investigates criteria used to assess the quality and impact of eHealth tools and highlights the complexity and challenges facing these initiatives. It demonstrates that there is no single framework that is used uniformly to assess the quality and impact of eHealth tools, and highlights the need for more a comprehensive approach that balances the social, organizational, and technical assessment criteria in a way that reflects the complexity and interdependence of the healthcare ecosystem, and is aligned with the factors impacting users' adoption to ensure uptake and stickiness on the long term. Clinicaltrial: Not applicable.
... Lastly, most existing assessment frameworks focus only on eHealth tools that are fully operational within the market, and do not necessarily tackle those that are still under development or not implemented yet [100]. One of the few assessment frameworks that look into specific criteria for the different phases of development and implementation cycle is the framework for the design and evaluation of digital health interventions (DEDHIs), developed by Kowatsch et al [109] categorizing the assessment criteria according to the phase in which the tool is in: preparation, optimization, evaluation, and implementation. ...
Preprint
Full-text available
BACKGROUND Technological advancements have opened the path to many technology providers to easily develop and introduce eHealth tools to the public. The use of these tools is increasingly recognized as a critical quality driver in healthcare, however, choosing a quality tool in the myriad of tools available for a specific health need doesn’t come without challenges. OBJECTIVE The aim of this review was to systematically investigate the literature to understand the different approaches and criteria used to assess the quality and impact of eHealth tools by considering sociotechnical factors (from technical, social, and organizational perspectives). METHODS A structured search was completed following the participants, intervention, comparators, and outcomes framework. We searched the PubMed, Cochrane, Web of Science, Scopus, and ProQuest databases for studies published between January 2012 and January 2022 in the English language, yielding 675 results, of which 40 studies met the inclusion criteria. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and the Cochrane Handbook were followed to ensure a systematic process. Extracted data were analyzed using NVivo (QSR International), with a thematic analysis, and narrative synthesis of emergent themes. RESULTS Similar measures from the different papers, frameworks, and initiatives were aggregated in 36 unique criteria grouped in 13 clusters. Using the sociotechnical approach, we classified the relevant criteria into technical, social, and organizational criteria. The technical assessment criteria were grouped in 5 clusters: technical aspects, functionality, content, data management, and design. The social assessment criteria were grouped in 4 clusters: human centricity, health outcomes, visible popularity metrics, and social aspects. And the organizational assessment criteria were grouped in 4 clusters: sustainability and scalability, health care organization, health care context, and developer. CONCLUSIONS This review builds on the growing body of research that investigates criteria used to assess the quality and impact of eHealth tools and highlights the complexity and challenges facing these initiatives. It demonstrates that there is no single framework that is used uniformly to assess the quality and impact of eHealth tools, and highlights the need for more a comprehensive approach that balances the social, organizational, and technical assessment criteria in a way that reflects the complexity and interdependence of the healthcare ecosystem, and is aligned with the factors impacting users’ adoption to ensure uptake and stickiness on the long term. CLINICALTRIAL NA
Preprint
Background Reproductive health conditions such as endometriosis, uterine fibroids and polycystic ovary syndrome affect a large proportion of women and people who menstruate worldwide. Prevalence estimates for these conditions range from 5-40% of women of reproductive age. Long diagnostic delays, up to 12 years, are common and contribute to health complications and increased healthcare costs. Symptom checker apps provide users with information and tools to better understand their symptoms and thus have the potential to reduce the time to diagnosis for reproductive health conditions. Objective This study aims to evaluate the accuracy of three symptom checkers developed by Flo Health assessing symptoms of endometriosis, uterine fibroids and polycystic ovary syndrome (PCOS) against current medical guidelines. Methods Independent general practitioners were recruited to create clinical case vignettes of simulated users with and without the conditions of interest. Vignettes were reviewed, modified and approved by separate general practitioners. A further independent panel of general practitioners reviewed the cases and designated a final classification. Vignettes were entered into the symptom checkers and the outcomes were compared with the final classification from the panel using accuracy metrics including percent agreement, sensitivity and specificity. Results A total of 24 cases were created per condition. Overall, exact matches between the vignette classification and the symptom checker outcome was 83.3% for endometriosis and uterine fibroids, and 87.5% for PCOS. While sensitivity was high for all conditions (>81%) and very high (100%) for PCOS, specificity was >81% for endometriosis and uterine fibroids and 75% for PCOS. Conclusion The single condition symptom checkers have high levels of accuracy for endometriosis, uterine fibroids and PCOS. Given long delays in diagnosis for many reproductive health conditions, which lead to increased medical costs and potential health complications for individuals and healthcare providers, innovative health apps and symptom checkers hold the potential to improve care pathways.
Article
Background: Health care systems have become increasingly more reliant on patients' ability to navigate the digital world. However, little research has been conducted on why some communities are less able or less likely to successfully engage with digital health technologies (DHTs), particularly among culturally and linguistically diverse (CaLD) populations. Objective: This systematic review aimed to determine the barriers to and facilitators of interacting with DHTs from the perspectives of CaLD population groups, including racial or ethnic minority groups, immigrants and refugees, and Indigenous or First Nations people. Methods: A systematic review and thematic synthesis of qualitative studies was conducted. Peer-reviewed literature published between January 2011 and June 2022 was searched across 3 electronic databases. Terms for digital health were combined with terms for cultural or linguistic diversity, ethnic minority groups, or Indigenous and First Nations people and terms related to barriers to accessing digital technologies. A qualitative thematic synthesis was conducted to identify descriptive and analytical themes of barriers to and facilitators of interacting with DHTs. Quality appraisal was performed using the Mixed Methods Appraisal Tool. Results: Of the 1418 studies identified in the electronic search, a total of 34 (2.4%) were included in this review. Half of the included studies (17/34, 50%) were conducted in the United States. There was considerable variation in terms of the CaLD backgrounds of the participants. In total, 26% (9/34) of the studies focused on Indigenous or First Nations communities, 41% (14/34) were conducted among ethnic minority populations, 15% (5/34) of the studies were conducted among immigrants, and 18% (6/34) were conducted in refugee communities. Of the 34 studies, 21 (62%) described the development or evaluation of a digital health intervention, whereas 13 (38%) studies did not include an intervention but instead focused on elucidating participants' views and behaviors in relation to digital health. From the 34 studies analyzed, 18 descriptive themes were identified, each describing barriers to and facilitators of interacting with DHTs, which were grouped into 7 overarching analytical themes: using technology, design components, language, culture, health and medical, trustworthiness, and interaction with others. Conclusions: This study identified several analytic and descriptive themes influencing access to and uptake of DHTs among CaLD populations, including Indigenous and First Nations groups. We found that cultural factors affected all identified themes to some degree and that cultural and linguistic perspectives should be considered in the design and delivery of DHTs, with this best served through the inclusion of the target communities at all stages of development. This may improve the potential of DHTs to be more acceptable, appropriate, and accessible to population groups currently at risk of not obtaining the full benefits of digital health.
Article
Full-text available
Background Climate change is projected to increase environmental health hazard risks through fire-related air pollution and increased airborne pollen levels. To protect vulnerable populations, it is imperative that evidence-based and accessible interventions are available. The environmental health app, AirRater, was developed in 2015 in Australia to provide information on multiple atmospheric health hazards in near real time. The app allows users to view local environmental conditions, and input and track their personal symptoms to enable behaviors that protect health in response to environmental hazards. Objective This study aimed to develop insights into users’ perceptions of engagement, comprehension, and trust in AirRater to inform the future development of environmental health apps. Specifically, this study explored which AirRater features users engaged with, what additional features or functionality needs users felt they required, users’ self-perception of understanding app information, and their level of trust in the information provided. Methods A total of 42 adult AirRater users were recruited from 3 locations in Australia to participate in semistructured interviews to capture location- or context-specific experiences. Participants were notified of the recruitment opportunity through multiple avenues including newsletter articles and social media. Informed consent was obtained before participation, and the participants were remunerated for their time and perspectives. A preinterview questionnaire collected data including age range, any preexisting conditions, and location (postcode). All participant data were deidentified. Interviews were recorded, transcribed, and analyzed using thematic analysis in NVivo 12 (QSR International). Results Participants discussed app features and functionality, as well as their understanding of, and trust in, the information provided by the app. Most (26/42, 62%) participants used and valued visual environmental hazard features, especially maps, location settings, and hazard alerts. Most (33/42, 78%) found information in the app easy to understand and support their needs, irrespective of their self-reported literacy levels. Many (21/42, 50%) users reported that they did not question the accuracy of the data presented in the app. Suggested enhancements include the provision of meteorological information (eg, wind speed or direction, air pressure, UV rating, and humidity), functionality enhancements (eg, forecasting, additional alerts, and the inclusion of health advice), and clarification of existing information (eg, symptom triggers), including the capacity to download personal summary data for a specified period. Conclusions Participants’ perspectives can inform the future development of environmental health apps. Specifically, participants’ insights support the identification of key elements for the optimal development of environmental health app design, including streamlining, capacity for users to customize, use of real time data, visual cues, credibility, and accuracy of data. The results also suggest that, in the future, iterative collaboration between developers, environmental agencies, and users will likely promote better functional design, user trust in the data, and ultimately better population health outcomes.
Article
Full-text available
Introduction: Physical therapists in Myanmar use a prescriptive model of Clinical Decision Making (CDM). Improving CDM effectiveness is one essential factor in professionalizing practice and enhancing patient outcomes. This study assesses the changes in CDM skills and behaviors using the PRECEDE-PROCEED planning Model (PPM). Methods: In the PRECEDE planning phases, we investigated the current clinical decision making knowledge, and process, clinical practice culture, and contributing factors of CDM among Myanmar physical therapists. A qualitative approach consisted of 18 in-depth interviews and one focus group discussion was used. In the PROCEED evaluation and implementation phases, we developed and presented the CDM educational book at CDM workshop, which was a 4-day intensive program in Yangon, Myanmar with 34 participants. The participant's CDM knowledge and processes were assessed before and after the educational program to explore the potential impact on implementing CDM which can ultimately improve patient care in the health settings of Myanmar. Results: In the PRECEDE phases, we explored the predisposing and reinforcing factors of Myanmar physical therapists' CDM. We found that CDM models and deliberative decision making process that is used internationally were not followed by Myanmar physical therapists who followed the physician's prescriptions. Teaching and learning emphasize a stimulus-response-repeat-outcome cycle without internal processing or application to clinical situations. Using the PROCEED model components, we developed a 14 chapters CDM workbook and a 4-day workshop as a behavioral change intervention. Participants' prior technical CDM behavior was transformed into professional CDM behavior that included an understanding of clinical practice models and improvement in the cognitive process of CDM processes. The workbook coupled with the intensive active-learning, hands-on workshop of examination and intervention procedures were effective in improving CDM. Discussion: The application of PPM provided a through understandings of current CDM process of Myanmar therapists and aided in the development of the tailored CDM educational program to improve participants' CDM. Using the PPM model for developing a set of Physical Therapy educational content and curriculum was new. The application of PPM was beneficial to use accepted clinical practice models, standardized tests and measures, set goals and clinical outcomes, reassessed to determine change and implement evidence-based practice.
Article
Full-text available
Background: Currently, there are no binding requirements for manufacturers prescribing which information must be included in the app descriptions of health apps. Objective: The aim of this study was to investigate how medical students perceive a selection of quality principles, intended for usage decisions in the app context, and establish whether the information presented in a sample of app descriptions is perceived as sufficient for facilitating an informed usage decision. Methods: A total of 123 students (mean age 24.2 years, SD 3.4) participating in a 6-week teaching module covering cardiology and pulmonology at the University of Göttingen (original enrollment 152 students, response rate 80.9%) were included. Students were asked to read 3 store description texts of cardiological or pneumological apps and initially assess whether the descriptions sufficed for a usage decision. Subsequently, they were queried on their perception of the relevance of 9 predefined quality principles, formulated for usage decisions. An appraisal of whether the app description texts contained sufficient information to satisfy these quality principles followed. By means of 20 guiding questions, participants were then asked to identify relevant information (or a lack thereof) within the descriptions. A reassessment of whether the description texts sufficed for making a usage decision ensued. A total of 343 complete datasets were obtained. Results: A majority of the quality principles were described as “very important” and “important” for making a usage decision. When accessed via the predefined principles, students felt unable to identify sufficient information within the app descriptions in 68.81% (2124/3087) of cases. Notably, information regarding undesired effects (91.8%, 315/343), ethical soundness (90.1%, 309/343), measures taken to avert risks (89.2%, 306/343), conflicts of interest (88.3%, 303/343), and the location of data storage (87.8%, 301/343) was lacking. Following participants’ engagement with the quality principles, statistically significant changes in their assessment of whether the app descriptions sufficed for a usage decision can be seen—McNemar-Bowker test (3)=45.803919, P<.001, Cohen g=.295. In 34.1% (117/343) cases, the assessment was revised. About 3 quarters of changed assessments were seen more critically (76.9%, 90/117). Although, initially, 70% (240/343) had been considered “sufficient,” this rate was reduced to 54.2% (186/343) in the second assessment. Conclusions: In a considerable number of app descriptions, participants were unable to locate the information necessary for making an informed usage decision. Participants’ sensitization to the quality principles led to changes in their assessment of app descriptions as a tool for usage decisions. Better transparency in app descriptions released by manufacturers and the exposure of users to quality principles could collectively form the basis for well-founded usage decisions.
Article
Full-text available
Background: Chronic back pain is associated with significant burden, yet few epidemiological studies have provided data on chronic back pain, its predictors and correlates in France. Methods: Data were drawn from a cross-sectional survey conducted in France (n = 17,249) using computer-assisted telephone interviews. Sample age ranges from 18 to 98 with a mean of 46.39 years (SD = 17.44), and was 56.7% female. Medical conditions were assessed using the CIDI, quality of life was assessed using both the physical and mental component scores of the SF-36. Results: Overall, 38.3% of adults reported chronic back pain. Female gender, older age, lower education, manual labor occupation, and population density were significantly associated with the distribution of chronic back pain. Chronic back pain was associated with lower scores on all SF-36 mean scores and on the Physical Composite Score and Mental Composite Score controlling for comorbid medical conditions including other types of chronic pain. Conclusion: The study highlights the burden of chronic back pain in the general population and underscores its correlation with quality of life. Such data contribute to raise awareness among clinicians and health policy makers on the necessity of prevention, early diagnosis, proper management and rehabilitation policies in order to minimize the burden associated with chronic pain.
Book
This book presents a framework for development, optimization, and evaluation of behavioral, biobehavioral, and biomedical interventions. Behavioral, biobehavioral, and biomedical interventions are programs with the objective of improving and maintaining human health and well-being, broadly defined, in individuals, families, schools, organizations, or communities. These interventions may be aimed at, for example, preventing or treating disease, promoting physical and mental health, preventing violence, or improving academic achievement. This volume introduces the Multiphase Optimization Strategy (MOST), pioneered at The Methodology Center at the Pennsylvania State University, as an alternative to the classical approach of relying solely on the randomized controlled trial (RCT). MOST borrows heavily from perspectives taken and approaches used in engineering, and also integrates concepts from statistics and behavioral science, including the RCT. As described in detail in this book, MOST consists of three phases: preparation, in which the conceptual model underlying the intervention is articulated; optimization, in which experimentation is used to gather the information necessary to identify the optimized intervention; and evaluation, in which the optimized intervention is evaluated in a standard RCT. Through numerous examples, the book demonstrates that MOST can be used to develop interventions that are more effective, efficient, economical, and scalable. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions: The Multiphase Optimization Strategy is the first book to present a comprehensive introduction to MOST. It will be an essential resource for behavioral, biobehavioral, and biomedical scientists; statisticians, biostatisticians, and analysts working in epidemiology and public health; and graduate-level courses in development and evaluation of interventions.
Conference Paper
Telemedicine is said to change the way care is delivered. Nevertheless, it still faces barriers to overcome the pilot stage and reach a majority of patients in regular care. Although research widely exists on telemedicine barriers in isolated settings, a systematic overview to summarize key scientific contributions is missing. This paper aims to close this gap with a systematic review of already existing reviews. In sum, 98 barriers for telemedicine implementation were found and categorized depending on the factors triggering the barriers. These factors include patient, healthcare provider, culture and disease (people-related); health sector, standards/guidelines, legal framework, finance, organization and methodology (process-related); and technology (object-related). Recommendations for researchers and practitioners were drawn to overcome the barriers identified.
Article
Objective: To present a guiding framework from the perspective of psychologists and technologists to develop effective mobile health (mHealth) interventions for pediatric populations. Methods: This topical review uses the IDEAS framework as an organizational method to summarize current strategies to conceptualize, design, evaluate, and disseminate mHealth interventions. Results: Incorporating theories of behavior change and feedback from target populations are essential when developing mHealth interventions. Following user-centered approaches that fully incorporate end users into design and development stages increases the likelihood that the intervention will be acceptable. Iterative design cycles and prototyping are important steps to gather user feedback to optimize an mHealth intervention. Broad sharing of knowledge and products generated during intervention development also is recommended. Assessment of behavioral principles, intervention components, or a full intervention package should be conducted to evaluate usability and efficacy. Conclusions: Pediatric health-care researchers and clinicians are increasingly using mHealth technology to target health behaviors and improve related outcomes. Pediatric psychologists should consider applying the design strategies outlined in the IDEAS framework to produce and disseminate mHealth interventions tailored to the specific needs of pediatric populations.
Article
Health care in the United States is the most expensive in the world, yet health care quality is highly variable.¹ Health apps have the potential to improve efficiency and value while lowering costs. More than 325 000 health apps have been developed, with increasing investment during the past decade. If health apps are to be successful and broadly adopted, patients and clinicians must have confidence that they are safe and effective.